TCI Wealth Advisors’s BioNTech BNTX Stock Holding History

TCI Wealth Advisors’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-84	Closed	-$10.5K	–	478
2023 Q1	$10.5K	Hold	84	–	–	﹤0.01%	1063
2022 Q4	$12.6K	Hold	84	–	–	﹤0.01%	917
2022 Q3	$11K	Hold	84	–	–	﹤0.01%	951
2022 Q2	$13K	Hold	84	–	–	﹤0.01%	839
2022 Q1	$14K	Hold	84	–	–	﹤0.01%	867
2021 Q4	$22K	Buy	+84	New	+$23K	﹤0.01%	658

Other funds holding BNTX

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCI Wealth Advisors's BNTX Position: Q2 2023 in Review

TCI Wealth Advisors sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 84 shares — an estimated $10.5K sold.

TCI Wealth Advisors first reported a position in BNTX in Q4 2021 and held it in 6 quarters. The position peaked at $22K in Q4 2021. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

TCI Wealth Advisors reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
TCI Wealth Advisors sold 84 BioNTech shares in Q2 2023, an estimated $10.5K.
TCI Wealth Advisors first reported a position in BioNTech in Q4 2021 and held it in 6 quarters.
TCI Wealth Advisors's BioNTech position peaked at $22K in Q4 2021.
253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.